Jounce Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD
Article By: Sweta Killa
Thursday, November 21, 2019 1:37 PM EDT
Here are five healthcare ETFs and stocks that are leading the market so far this quarter. These could be excellent plays for investors if similar trends continue.
In this article: SEM, GNOM, IRWD, BDSI, IHF, BBC, SBIO, CNCR, JNCE, OSMT
Read
5 High-Beta ETFs & Stocks For A Record Market
Article By: Sweta Killa
Monday, November 11, 2019 12:02 PM EDT
Given the positivity, high-beta products will continue to generate outsized returns in the coming weeks and are suitable for risk-tolerant investors, given their volatile nature.
In this article: SPHB, ENTR, HEES, RFV, RZV, CVEO, SQ, JNCE, VFVA, HNGR
Read
Loxo Gains, Jounce Plunges After Cancer Meeting Abstracts Released
Article By: The Fly
Thursday, May 17, 2018 5:10 PM EDT
Shares of Loxo Oncology jumped in after the biotech company released data in abstracts in anticipation of the 2018 American Society of Clinical Oncology Annual Meeting that is being held June 1-5 in Chicago.
In this article: LOXO Also: BMY, JNCE, NKTR
Read
5 Best ETF Charts Of Q4 Earnings
Article By: Sweta Killa
Tuesday, March 6, 2018 12:24 PM EDT
Several equity ETFs have impressed with their performances and generated handsome returns over the trailing one month even after being hit by the market rout triggered by inflation fears and higher-than-expected rates hike.
In this article: FTXL, CNCR, TAN, IBUY, XAR Also: SPY, NKTR, JNCE, MGNX, GLD, FSLR, SEDG
Read

Latest Tweets for $JNCE

No tweets yet!

PARTNER HEADLINES